FDA Inspection 1225659 — Stefan Daniluk, MD
The FDA completed an inspection of Stefan Daniluk, MD on December 14, 2023 in Bialystok. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bialystok (Poland)
Additional Details
Clinical Investigator (CI)